. 2017 Jul 15;31(8):685–697. doi: 10.1007/s40263-017-0455-7
© Shire Development LLC 2017
Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Fig. 1.
Study design. ET early termination, MAS mixed amphetamine salts, PBO placebo, V visit